NCT03158064 2026-01-28
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT04876456 2026-01-15
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Indiana University
Phase 2 Active not recruiting
NCT05634785 2026-01-09
CD30 CAR for CD30+ NSGCT
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT06133543 2025-09-15
RAISN
Heinrich-Heine University, Duesseldorf
Phase NA Recruiting
NCT06418789 2025-08-03
GERMAN
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Recruiting
NCT06967961 2025-07-29
DP-PAN-CANCER
Institut Claudius Regaud
Phase NA Recruiting
NCT05705687 2025-05-08
VAPOR
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT04804007 2025-04-18
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Indiana University
Phase 2 Recruiting